Skip to main content
letter
. 2020 Nov 21:dkaa477. doi: 10.1093/jac/dkaa477

Figure 1.

Figure 1.

Compilation of ORs for COVID-19 infection in HCWs receiving hydroxychloroquine PrEP for COVID-19, assessed by either reverse real-time PCR (a) or by SARS-CoV-2 antibodies (b).